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Abstract The present paper reviews the diagnosis of imported
malaria in children. Malaria is caused by a parasite called
Plasmodium and occurs in over 100 countries worldwide.
Children account for 10–15% of all patients with imported
malaria and are at risk to develop severe and life-threatening
complications especially when infected with Plasmodium
falciparum. Case–fatality ratios vary between 0.2% and
0.4%. Children visiting friends and relatives in malaria
endemic areas and immigrants and refugees account for the
vast majority of cases. Symptoms are non-specific and
delayed infections (more than 3 months after return from an
endemic country) may occur. Microscopic analysis of the
thick blood film is the cornerstone of laboratory diagnosis. For
pragmatic reasons, EDTA-anticoagulated blood is accepted,
provided that slides are prepared within 1 h after collection.
Information about the Plasmodium species (in particular P.
falciparum versus the non-falciparum species) and the
parasite density is essential for patient management. Molec-
ular methods in reference settings are an adjunct for species
differentiation. Signals generated by automated hematology
analyzers may trigger the diagnosis of malaria in non-
suspected cases. Malaria rapid diagnostic tests are reliable in
the diagnosis of P. falciparum but not for the detection of the
non-falciparum species. They do not provide information
about parasite density and should be used as an adjunct (and
not a substitute) to microscopy. In case of persistent suspicion
and negative microscopy results, repeat testing every 8–12 h
for at least three consecutive samplings is recommended. A
high index of suspicion and a close interaction with the
laboratory may assure timely diagnosis of imported malaria.
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Introduction
Malaria is endemic in over 100 countries worldwide [62].
In endemic regions, it is a serious health problem with an
estimated 863,000 people dying each year of which 85%
are children under the age of 5 years [59]. Imported
malaria, i.e., malaria contracted in an endemic region but
diagnosed in a non-endemic country [33], is a rare event
but may have a fatal outcome. Due to its rare occurrence,
physicians and laboratory staff are not familiar with its
diagnosis. Prompt and accurate diagnosis is, however,
critical for the effective management of malaria [44].
The present papergives an overview of the clinically relevant
features of the cycle of the Plasmodium parasite and a short
reminder of the clinical presentation of malaria in children.
Next, it focuses on the laboratory diagnosis of imported
malaria in a non-endemic setting and gives an update on the
diagnostic value and place of malaria rapid diagnostic tests.
The Plasmodium species
The parasite
Malaria is caused by a parasite called Plasmodium, which is
transmitted through the bites of the infected Anopheles
mosquito. There are four human Plasmodium species:
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DOI 10.1007/s00431-011-1451-4Plasmodium falciparum, Plasmodium vivax, Plasmodium
ovale, and Plasmodium malariae. Recently, human infec-
tions with a fifth species, Plasmodium knowlesi, which is
usually found in monkeys, have been reported [48]. Figure 1
depicts the life cycle of malaria parasites in humans. A
detailed description of the Plasmodium life cycle can be
found in reference [35].
The cycle in the human host: from liver to blood,
hypnozoites, relapse, and recrudescence
Plasmodium has a sexual cycle inside the mosquito and an
asexual cycle inside man. During the bite of an infected
female mosquito, Plasmodium sporozoites are injected in
the blood and move to liver cells where they develop into
liver schizonts. After the rupture of the schizonts (approx-
imately 1 week after infection), merozoites are released into
the bloodstream and each of them will invade a RBC. There
they develop into ring forms (trophozoites) which mature
into schizonts that divide into merozoites which invade new
RBCs. The rupture of the schizont and release of
merozoites give rise to the so-called malaria paroxysms
with spiking fever and rigors. The time required to
complete the RBC cycle (from invading merozoites over
trophozoites to rupturing schizont) depends on the species:
for P. falciparum, P. ovale, P. vivax, and P. ovale, the cycle
takes 48 h; for P. malariae and P. knowlesi, it takes 72 h
and 24 h, respectively. In non-immune patients, however,
particularly when infected with P. falciparum, parasites
tend to mature asynchronously, resulting in irregular fever
patterns [67].
After 1 or 2 weeks, gametocytes, the sexual form of
Plasmodium, will be produced. These gametocytes contin-
ue the sexual cycle when taken up by a mosquito during a
next blood meal. The sexual cycle will be completed over a
period of 2 weeks, where after the mosquito can infect
another human host.
In case of P. vivax and P. ovale infections, dormant liver
stages (hypnozoites) may cause infections (so-called relap-
ses) weeks to months after adequate prophylaxis or
effective blood-stage therapy of a primary infection. P.
malariae may persist in the blood at undetectable levels
without causing symptoms for many years and may
subsequently develop into clinical illness in patients under
Fig. 1 Plasmodium life cycle. Retrieved from Centers for Disease Control and Prevention (CDC). Available at http://www.cdc.gov/malaria/about/
biology/
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infections are referred to as recrudescence) [67].
The red blood cell: differences in parasite densities
among the Plasmodium species
P. vivax and P. ovale only infect young RBCs and P.
malariae only infects old RBCs; hence, the percentages of
infected RBCs (designated as “parasite density” or “para-
sitemia”) are usually lower than 2% and 1%, respectively.
By contrast, P. falciparum infection has not such a
preference and there is no intrinsic limit to the parasite
density. In addition, RBCs infected by P. falciparum stick
to the capillary endothelium and occlude the microvascular
circulation in the deep organs (a process called sequestra-
tion), leading to the manifestations of what is defined as
severe malaria: metabolic acidosis, cerebral malaria (coma),
renal insufficiency, and acute respiratory distress. In
addition, hypoglycemia can occur. By consequence, P.
falciparum is the most dangerous species, and infection
may become fatal when treatment is delayed for more than
24 h after presentation of symptoms [62]. The other species
are thought to be less severe though organ involvement and
case fatalities have been described for P. vivax as well [41].
Geographic distribution of Plasmodium species
P. falciparum is the predominant species in Africa, where P.
vivax is virtually absent (because most Africans lack the
Duffy blood group antigen which enables P. vivax to enter the
RBC), except for some areas in Eastern Africa. P. ovale is
mainly restricted to Africa; rare cases have been observed in
Haiti and Oceania. P. malariae is the second common species
in Africa and also distributed in other geographic areas. Latin
America is predominated by P. vivax though P. falciparum is
present as well. The same goes for the Indian sub-continent
and South-East Asia where P. malariae is also prevalent.
Imported malaria in children
Children at risk: few tourist travelers, mostly visiting
friends and relatives or immigrants
Yearly, more than 125 million international travelers visit
malaria endemic countries and over 10,000 people are
reported to fall ill upon return to their home country, though
this number might even be as high as 30,000 [62].
However, in most European countries, imported malaria
has been declining during the past 10 years [53]; possible
explanations are the increased use of prophylaxis or a
decreased transmission intensity in the visited malaria
endemic areas, though this remains to be confirmed [53].
Children account for 10–15% of all patients with
imported malaria [11, 23, 39]a n ds h a r ew i t hp r e g n a n t
women the highest risk to develop severe and life-
threatening complications [62]. Children of the so-called
visiting friends and relatives category (further referred to
as VFR children) are the main group at risk [47]. VFR
children are born in non-endemic countries to parents
originating from malaria endemic areas and contract
malaria upon visits to malaria endemic regions. Immigrat-
ed children and refugees are another risk group [47]. In an
Italian and a Spanish study, imported malaria in children
was exclusively observed among VFR children and
immigrants [1, 39]. These findings were confirmed in
other studies, with VFR children accounting for most of
the cases versus tourist travelers representing only a minor
part [11, 33, 34] .A m o n g1 9 4c h i l d r e nw i t hi m p o r t e d
malaria in the USA for the year 2004, more than half
(54.6%) were visiting friends and relatives, and more than
a quarter (28.3%) of them were refugees and immigrants.
Reasons for this phenomenon are that VFR children hardly
comply with preventive measures and have a poor
adherence to prophylactic drugs [1, 11, 33, 34, 39]. Their
parents have difficult access to travel advice due to
language and cultural barriers, and may also believe their
children have immunity against malaria because of their
ethnic origin, making prophylaxis unnecessary [33]. Semi-
immunity does exist in children, but only when born and
grown in endemic countries. This semi-immunity wanes
after a variable period (usually estimated at 6 months) of
not being exposed to malaria (as in the case of migrants
and refugees) [39, 49].
A particular group—strictly speaking not to be classified
as "import malaria"—are autochthonous malaria cases
caused by inadvertently imported Anopheles mosquitoes,
either by airplane, ship, or baggage. Although members of
airport staff are the primary victims, anecdotal cases of
"airport" or "baggage" malaria have been described in
children too [28–30]. As Anopheles mosquitoes survive
transports in aircrafts, WHO recommends insecticide
spraying in flights leaving endemic countries [57].
Non-specific symptoms but serious complications
A 2.5-year-based study in a district hospital in Birmingham,
UK assessed 153 children presenting with fever and having
traveled to the tropics or subtropics during the previous
year and revealed that 14% of them had malaria [54].
Although fever was reported as the major presenting
symptom in up to 97.6% of children with imported malaria
[24], other studies revealed that 10–17% of children with
malaria had no fever upon admission [1, 11]. Other
symptoms are non-specific and may mimic diseases like
gastrointestinal infections or pneumonia [8].
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were reported between 2004 and 2008, of which one third
fulfilled the WHO criteria for severe malaria [16]. Other
studies from the UK, the Netherlands, and Canada revealed
similar proportions [11, 32, 34]. The proportions of children
requiring intensive care support ranged from 3% to 40%
[11, 16, 34]; most of them survived without sequelae
though cerebellar infarction was observed in one out of 10
patients with cerebral malaria [16]. The case–fatality ratio
of all imported malaria cases in children varied between
0.2% and 0.4% [3, 16].
How long after return from an endemic country
can children develop malaria?
The time between returning home after travel and onset of
symptoms depends on the infecting Plasmodium species. In
a study including 245 children positive for malaria, the
median delay of P. falciparum infection was 5 days (range
0–330 days); for P. vivax, P. ovale, and P. malariae, the
recorded delays were 62 (0–330), 25 (0–120), and 37 days
(0–188), respectively [65]. It should be reminded, however,
that as a consequence of relapse (P. ovale and P. vivax) and
recrudescence (P. malariae), clinical malaria can occur even
at a later onset. Of interest, P. falciparum, which apparently
lacks both features, has been reported with a delayed onset
of infection in adults for up to 9 years after acquisition [9,
20, 21, 50].
Malaria diagnosis: patient delay, doctor delay, laboratory
delay
Diagnosis is delayed in one third of children with imported
malaria [4, 12, 65]. The median time between onset of
symptoms and diagnosis of malaria was recorded as 3–
4d a y s[ 4, 65]b u tc a ne x t e n du pt o3 2d a y s[ 65].
Importantly with regard to pre-travel advice was that most
delay was at the patient’s side, with parents waiting several
days before consulting, resulting in a median patient delay
of 3 days (range 0–11 days) [4]. The median doctor delay in
that study was 0 days (which means that in most cases
malaria was considered at the first presentation) but ranged
up to 19 days [4]. Other data about doctor delay are
variable, with 2% [1] to 60% [32] of doctors failing to
consider malaria at first presentation. Finally, there may be
a considerable laboratory delay, due to the lack of a
competent microbiologist on duty [1]o rt h el a c ko f
microscopic expertise [1, 4]. Indeed, in non-endemic
settings, since it is difficult to maintain adequate
performance and expertise of the laboratory staff due to
the low exposure to malaria-positive samples and
especially at low parasite densities, diagnosis may easily
be missed [18, 26, 40].
Plasmodium species involved
The Plasmodium species involved reflect the travel desti-
nation or the country of origin of the child or his/her
migrated parents. Overall, the most encountered species
was P. falciparum, accounting for up to 90% of cases, with
the majority of infections acquired in Sub-Saharan Africa
[11, 23, 34, 65]. P. vivax infections were mostly acquired in
the Indian sub-continent by VFR children whose parents
were originating from these regions [33]. Table 1 gives an
overview of the species distribution and geographic origin
of 147 children ≤14 years old diagnosed with malaria in our
setting (Institute of Tropical Medicine, Antwerp, Belgium).
The diagnosis of imported malaria in children
Essential information needed in the laboratory diagnosis
of malaria
All essential information for diagnosis and patient manage-
ment can be obtained by microscopy. Plasmodium parasites
are looked for in a thick blood film, which consists of a
superposition of several layers of blood cells. The RBCs are
Table 1 Malaria in children ≤14 years as diagnosed at the Institute of Tropical Medicine, Antwerp, Belgium during the period 1995–2010:
species distribution according to region of acquisition
Species Region where malaria was acquired Total (%)
East Africa Middle Africa West Africa Asia No data
P. falciparum 4 29 52 2 24 111 (75.5)
P. falciparum/P. malariae 2 2 (1.4)
P. malariae 2 2 3 7 (4.8)
P. ovale 3 3 4 10 (6.8)
P. vivax 3 2 1 10 1 17 (11.6)
Total (%) 9 (6.1) 36 (24.5) 61 (41.5) 12 (8.2) 29 (19.7) 147
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stain. Thin blood films—as regularly used in the hemato-
logical laboratory—represent a monolayer of blood, and are
used for Plasmodium species identification, which is based
on morphological characteristics of the RBCs (shape and
inclusions) and the Plasmodium parasites (Fig. 2).
Apart from not missing the diagnosis of malaria,
differentiation of P. falciparum from the non-falciparum
species is important because of the life-threatening
potential of this species. Accurate identification of parasite
density appears to be difficult in non-endemic settings
[31], but high parasite densities exceeding 2% of RBCs
infected should be recognized, as this criterion constitutes
an alert sign [61]. Expert microscopists in reference
laboratories will recognize P. falciparum stages and
hemozoin pigment in white blood cells (WBCs): in the
case of P. falciparum infection, schizonts and hemozoin-
containing WBCs are indicators of a serious infection,
whereas the exclusive presence of gametocytes after
treatment is a normal finding [60].
Capillary or venous blood?
Some authors recommend capillary rather than venous blood
as the sample of choice for malaria diagnosis because of a
presumed higher parasite density in the former [40, 43].
However, this assumption has never been confirmed [25]a n d
for pragmatic reasons, i.e., to assure preparation of (enough)
samples of good quality and to allow antigen testing and
confirmatory analysis, we advice in our setting to submit a
tube of EDTA blood rather than capillary blood specimens.
Details for sampling can be found in reference [36]. For
capillary blood, a non-cotton alcohol pad should be used for
cleaning as cotton may leave loose fibers resulting in
confusing artifacts [43]. Thick and thin blood films should
be prepared instantly: for the thick film, a blood spot is
applied on a slide and stirred in a circular motion with the
corner of the slide, taking care not to make the preparation too
thick. The slide is allowed to dry without fixative. For venous
blood, EDTA is the anticoagulant of choice. Slides should
p r e f e r a b l eb ep r e p a r e dw i t h i n1ha f t e rc o l l e c t i o ni no r d e rt o
preserve RBC alterations and parasite morphology [43].
Automated hematology analyzers may trigger
the possibility of malaria
Some automated hematology analyzers display an alert
(flag) in case of malaria suspicion based on the presence of
(1) activated monocytes (Coulter Counter), (2) hemozoin-
containing white blood cells (Cell-Dyn series), and (3) an
additional peak in the reticulocyte fraction (Cell-Dyn series)
[2, 27, 45, 55]. Although diagnostic accuracy of these
features is too low to exclusively rely on these flags for
malaria diagnosis, the merit of these analyzers is triggering
the diagnosis of malaria in patients for whom malaria
diagnosis was not requested. As an example, based on flags
g e n e r a t e db yC e l l - D y n3 2 0 0a p p a r a t u su s e di no u r
laboratory, we retrieved Plasmodium parasites in the blood
of seven patients over a 3-year period (2008–2010), for
whom malaria diagnosis was not considered upon clinical
presentation (including an 11-year-old boy with P. falcipa-
rum infection).
Molecular methods can refine the diagnosis
Molecular techniques such as polymerase chain reaction
(PCR) are powerful tools with detection limits below that of
expert microscopy. For the time being, they do not generate
information about parasite density and their turnaround
time is too long to be practicable in clinical diagnosis. In
our setting, we developed a real-time four-primer Plasmo-
dium-specific PCR as a back-up method for species
confirmation and diagnosis of mixed Plasmodium infec-
tions [6]. We also converted this method to Giemsa-stained
slides and malaria rapid diagnostic tests as the source of
DNA, which makes it possible to confirm or refine the
diagnosis even when whole blood samples are not available
[5, 7].
Malaria rapid diagnostic tests (MRDTs): simple
and accurate
Malaria rapid diagnostic tests (MRDTs) detect Plasmo-
dium antigen by an antibody–antigen reaction on a
Fig. 2 Giemsa-stained thin blood film of a patient with P. falciparum
malaria: the patient was sick for 2 weeks before diagnosis. Numerous
red blood cells are infected with small trophozoites (ring forms); some
red blood cells contain multiple trophozoites. Three banana-shaped
gametocytes (visible only after 1 or 2 weeks of clinical infection) are
present and the white blood cell (center) contains black-brown
hemozoin pigment
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cassette or occasionally in a cardboard format (Fig. 3).
Malaria-positive samples will present cherry-red test lines
which are read by the naked eye. Two-band MRDTs are
mostly designed to detect P. falciparum; they display a
control line and a test line which targets either histidine-
rich protein-2 (HRP-2) or P. falciparum-specific parasite
lactate dehydrogenase (Pf-pLDH). Three- and four-band
malaria MRDTs display a control line and two or three test
lines, one targeting a P. falciparum-specific antigen,
another line targeting an antigen common to the four
species [either pan-Plasmodium-specific lactate parasite
dehydrogenase (pan-pLDH) or aldolase], and, in case of
the four-band malaria RDTs, a third line which targets P.
vivax-specific pLDH (Pv-pLDH).
Figure 4 displays the different components of a MRDT
strip and the sequence of reactions on a two-band MRDT
strip. Before interpreting test results, the presence of the
control line should be confirmed and when absent the test
should be repeated. In case of three-band MRDTs, the
presence of a single P. falciparum-specific test line
indicates an infection with P. falciparum and the presence
of a single pan-Plasmodium test line indicates an infection
with one of the non-falciparum species. When both test
lines are present, this indicates an infection with either P.
falciparum or a mixed infection of P. falciparum and one or
more of the non-falciparum species.
Malaria rapid diagnostic tests: different accuracies
for the four Plasmodium species
Nowadays more than 80 MRDT brands are marketed
worldwide [10] and their diagnostic performances may
vary. WHO has published two series of diagnostic evalua-
tions [58, 63] and we have evaluated a set of MRDTs
available on the European market [36, 37, 51, 52]. No
studies about diagnostic accuracies of MRDTs in the setting
of imported childhood malaria are available, though MRDT
performances are assumed not to be different in children
compared to adults [42].
For the diagnosis of P. falciparum, MRDTs approach a
sensitivity of 100% but they perform less well below
parasite densities of 100/μl (corresponding to 0.002% of
RBCs). This detection limit generally is above the threshold
Fig. 3 Two- and three-band (below) malaria rapid diagnostic tests
(MRDTs) with blood transfer devices (pipette and loop). Control and
test lines are cherry-red colored. The two-band MRDT (upper)
displays a control line and a test line which targets P. falciparum-
specific histidine-rich protein-2 (HRP-2) The three-band MRDT
(below) displays a control line and two test lines, one targeting
HRP-2 and another line targeting pan-parasite lactate dehydrogenase
Fig. 4 Schematic drawing of the malaria rapid diagnostic test.
Sequence of events when performing a MRDT: blood and buffer are
applied, respectively, to the sample and buffer pad. They are attracted
by the capillary action of the absorption pad and start to migrate. First,
they pass the conjugate pad, which contains a detection antibody
targeting a Plasmodium antigen, such as HRP-2, Pf-pLDH, Pv-pLDH,
pan-pLDH, or aldolase (for abbreviations see text). This detection
antibody is a mouse antibody that is conjugated to a signal, mostly
colloidal gold. If present in the sample, the Plasmodium antigen is
bound to this detection antibody–conjugate. Next, the antigen–
antibody–conjugate complex migrates further until it is bound to the
capture antibody, which binds to another site of the Plasmodium target
antigen. As the capture antibody is applied on a narrow section of the
strip, the complex with the conjugated signal will be concentrated and
by virtue of the colloidal gold will become visible as a cherry-red line.
The excess of detection antibody–conjugate that was not bound by the
antigen and the capture antibody moves further until it is bound to a
goat-raised anti-mouse antibody, thereby generating a control line
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microscopy in non-endemic settings, which has been shown
to be close to 500/μl[ 40]. Of note, however, non-immune
travelers can present with symptoms below a parasite
density of 100/μl parasite density [42].
Concerns have risen about rare but persistent reports of
false-negative MRDT results at higher parasite densities.
One of the explanations is the hrp gene deletions that have
been found in P. falciparum samples in the Peruvian
Amazon [15]. These parasites do not secrete HRP-2,
thereby impeding diagnosis by HRP-2-based MRDTs.
Further, MRDTs may generate false-negative results in
cases of high parasite densities (>5% of RBCs infected).
This is the so-called prozone effect, caused by an excess of
antigen blocking the binding sites of both detection and
capture antibodies [17].
For the non-falciparum species, reported diagnostic
sensitivities vary more and are lower than for P. falciparum
[38]. Several MRDT brands have been evaluated at our
institute on stored whole blood samples. Reported sensitiv-
ities for P. vivax ranged from 66.0% to 92.9% with false-
negative results especially occurring at low parasite
densities [36, 37, 51, 52]. For P. ovale and P. malariae,
sensitivities were 5.5–80.0% and 21.4–45.2%, respectively
[36, 37, 51, 52]. The lower diagnostic sensitivities for P.
ovale and P. malariae are well known and might be
explained by the lower affinity of some monoclonal
antibodies to these species [22]. Though MRDTs can be
of help in the diagnosis of malaria, they cannot be used to
reliably exclude the non-falciparum species, especially P.
ovale and P. malariae.
Malaria rapid diagnostic tests are not fail-proof
and have inherent weaknesses
Although useful in the diagnosis of malaria and for the
species identification of P. falciparum, MRDTs do not
provide a reliable indication about parasite density. In
addition, the HRP-2 antigen may persist for weeks after
treatment and clearing of the parasites [38, 40, 42, 66],
giving rise to apparent false-positive results. Limitations
may also arise in performance and interpretation. For
instance, problems can occur with the blood transfer device
supplied with the MRDT kit (a loop, pipette or a straw—
Fig. 3) which may be too small to manipulate accurately
[64], reason why we advice a transfer pipette. Disregarding
faint test lines as negative results is a frequent error among
end users [46], and this is of concern as faint test lines
(which are barely visible to the naked eye) may occur in
17.8% of all positive test lines [37]. Further, reading
beyond the recommended reading time must be avoided
as this may cause false-positive results [56]. Finally,
inadequacies in MRDT package, labeling, and test instruc-
tions have been reported also among CE-labeled kits [18,
19], which might limit accurate performance and/or test
interpretation by end users.
The diagnostic strategy, some comments
There is a tendency among clinical laboratories in non-
endemic settings to rely on MRDTs as the single tool for
the diagnosis of malaria (especially outside office hours),
but for reasons of their limitations, MRDTs should only be
used as an adjunct to microscopy. The clinician, who in
some cases decides about which laboratory analyses is
going to be performed for the diagnosis of malaria, should
request both microscopy and MRDTs when filling in the
laboratory request form [18].
Non-immune children may present with symptoms at
parasite densities below the detection thresholds of both
microscopy and MRDTs. Therefore, laboratory testing after
unexpected negative results should be repeated. Repeat
testing has been advised every 8–12 h for at least three
consecutive samplings [13, 14, 67]. Of note, there is no
need to await a next peak of fever to repeat microscopy or
MRDT testing [42].
Conclusion
From the above, it is clear that a high index of clinical
suspicion and close communication with the laboratory are
clues to the timely diagnosis of malaria. VFR children,
immigrants, and refugees belong to the highest risk group.
Malaria may present months after leaving an endemic area,
also in case of P. falciparum. Microscopy remains the
cornerstone of diagnosis and provides information about
parasite density and Plasmodium species. It can be
complemented by MRDTs which are accurate for the
diagnosis and distinction of P. falciparum but lack
sensitivity for the diagnosis of the non-falciparum species.
Repeat testing is recommended in case of negative
laboratory tests and persistent suspicion of malaria.
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